Cerebrospinal fluid (CSF) biomarkers amyloid beta 1–42 (Aβ42), total tau (tau), and tau phosphorylated at threonine 181 (ptau-181) reflect the neuropathology of AD and are useful as diagnostic markers for AD [5]. Here, MAPT is linked to Alzheimer disease.